Structures by: Monforte A. M.
Total: 6
1-(3,5-Ditrifluoromethylphenyl)-1H,3H-thiazolo[3,4-a]benzimidazole
C17H10F6N2S
Acta Crystallographica Section C (1996) 52, 10 2533-2535
a=8.281(2)Å b=20.914(4)Å c=9.549(2)Å
α=90.00° β=97.46(2)° γ=90.00°
1-Fluoromethyl-1-methyl-1H,3H-thiazolo[3,4-a]benzimidazole
C11H11FN2S
Acta Crystallographica Section C (1996) 52, 10 2531-2533
a=8.127(1)Å b=6.985(1)Å c=9.306(2)Å
α=90.00° β=97.20(1)° γ=90.00°
1-(2,4-difluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole
C15H10F2N2S
Acta Crystallographica Section C (1997) 53, 9 1337-1341
a=11.507(2)Å b=7.3990(10)Å c=15.802(2)Å
α=90.00° β=106.830(10)° γ=90.00°
1-(2,6-dichlorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole
C15H10Cl2N2S
Acta Crystallographica Section C (1997) 53, 9 1337-1341
a=7.740(2)Å b=13.030(5)Å c=14.694(5)Å
α=83.30(3)° β=79.20(3)° γ=76.72(3)°
1-(2-chloro-6-fluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole
C15H10ClFN2S
Acta Crystallographica Section C (1997) 53, 9 1337-1341
a=22.093(5)Å b=7.8780(10)Å c=31.473(5)Å
α=90.00° β=100.28(3)° γ=90.00°
3-[2-(1<i>H</i>-1,3-benzodiazol-2-yl)ethyl]-1,3-oxazolidin-2-one
C12H13N3O2
Acta Crystallographica Section E (2011) 67, 5 o1083
a=6.0940(2)Å b=18.1570(6)Å c=10.0740(3)Å
α=90° β=90.6960(10)° γ=90°